Newsroom
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in the San Antonio Express-News. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read […]
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in the Associated Press. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read story
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in HealthDay News. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read story
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in the Washington Post. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19. Read story
July 30, 2021
Dr. Gabriel A. de Erausquin, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, had his team’s study reported in Forbes. The study, conducted in Argentina, found that adults over the age of 60 were likely to have issues with cognitive function, such as memory loss and confusion, after a COVID-19 infection. Read story
July 29, 2021
Loss of smell also observed in Argentine sample. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu DENVER, Colo. (July 29, 2021) — In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San […]
